Study title:
A comparative study of the treatment of seasonal rhinoconjunctivitis with
levocabastine, up-to date and classical H1 inhibitors.
18"' Congress of the European Academy of Allergy and Clinical Immunology,
Brussels, Belgium, NO-P292, July 3-7, 1999A comparative study of the treatment of seasonal rhinoconjunctivitis with
levocabastine, up-to date and classical H1 inhibitors.
18"' Congress of the European Academy of Allergy and Clinical Immunology,
Brussels, Belgium, NO-P292, July 3-7, 1999
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area:
|
Brands: |
MAH holders: Please see report |
Assessment: |
Active substance: LEVOCABASTINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|